START-UP INITIATIVE

by Max Planck Förderstiftung

SaLux

SaLux is a project initiated in the early phases of the Covid-19 pandemic at the Max-Planck- Institute of Experimental Medicine (now Max-Planck-Institute for Multidisciplinary Sciences).

Altbiotics

Infectious diseases contribute to more than 25% of human morbidity. The arsenal of antimicrobial agents is rapidly being depleted as existing pathogens continue to develop resistance against most of the frontline drugs. According to O’Neill commission, Antimicrobial resistance (AMR) is predicted to incur a huge dent to world economy and cost 10 million lives by 2050.

Print E-Mail

The Max Planck Foundation is the private, independent, non-profit organization of private supporters of top research in the Max Planck Society. Thanks to dedicated donors, it makes possible innovative and trendsetting research in sciences and the humanities at Max Planck Institutes. The focused support by the Max Planck Foundation enabled breakthroughs in research and, among other things, the work of Nobel Laureates in Germany.

Bank account
Max Planck Foundation
Deutsche Bank
IBAN: DE46 7007 0010 0195 3306 00
BIC/SWIFT: DEUTDEMMXXX

NEWSLETTER OF THE MAX PLANCK FOUNDATION:


By clicking on “subscribe” I agree to the processing of my personal data according to the Privacy Policy.
©2025 Max Planck Foundation |

Imprint | Privacy & Disclaimer | Privacy Settings